Bio-Rad Laboratories (BIO) Receivables - Net (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Receivables - Net data on file, last reported at $426.2 million in Q1 2026.

• On a quarterly basis, Receivables - Net changed 0.35% year-over-year to $426.2 million in Q1 2026; TTM through Mar 2026 was $426.2 million, a 0.35% change from a year earlier, with the FY2025 full-year figure at $460.6 million, up 1.79% from the prior year.
• Receivables - Net for Q1 2026 stood at $426.2 million, down from $460.6 million in the prior quarter.
• Over the last five years, Receivables - Net for BIO reached as high as $498.3 million in Q1 2023 and fell as low as $424.7 million in Q1 2025.
• Historically, Receivables - Net has averaged $460.5 million across 5 years, with a median of $460.6 million in 2025.
• Across the five-year window, Receivables - Net increased 16.79% in 2022 and dropped 10.73% in 2024, its largest moves.
• Year by year, Receivables - Net stood at $494.6 million in 2022, then dropped by 1.14% to $489.0 million in 2023, then retreated by 7.46% to $452.5 million in 2024, then rose by 1.79% to $460.6 million in 2025, then declined by 7.47% to $426.2 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $426.2 million in Q1 2026, $460.6 million in Q4 2025, and $464.7 million in Q3 2025.